FDA PMA FDA Class 3 Approved 🇺🇸 United States

Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode

PMA: P010015 · Supplement: S166 · Decision Mar 13, 2013
Classifications
1
FEI Numbers
22
Registration Numbers
22

Basic Information

Device Name
Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode
Trade Name
INSYNC III (MODEL 9981 V8.0)
PMA Number
P010015
Supplement Number
S166
Device Class
FDA Class 3
Product Code
OJX
Generic Name
Drug eluting permanent left ventricular (lv) pacemaker electrode
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
March 13, 2013
Date Received
July 17, 2012
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR THE INSYNC III, CONSULTA CRT-P, SYNCRA CRT-P.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OJX Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode